Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

One-year treatment persistence with local estrogen therapy in postmenopausal women diagnosed as having vaginal atrophy.

Portman D, Shulman L, Yeaw J, Zeng S, Uzoigwe C, Maamari R, Iyer NN.

Menopause. 2015 Nov;22(11):1197-203. doi: 10.1097/GME.0000000000000465.

PMID:
25944522
2.
3.

The effect of estradiol vaginal tablet and conjugated estrogen cream on urogenital symptoms in postmenopausal women: a comparative study.

Manonai J, Theppisai U, Suthutvoravut S, Udomsubpayakul U, Chittacharoen A.

J Obstet Gynaecol Res. 2001 Oct;27(5):255-60.

PMID:
11776507
4.

Local oestrogen for vaginal atrophy in postmenopausal women.

Suckling J, Lethaby A, Kennedy R.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD001500. Review. Update in: Cochrane Database Syst Rev. 2016;8:CD001500.

PMID:
17054136
5.

Effect of raloxifene on the response to conjugated estrogen vaginal cream or nonhormonal moisturizers in postmenopausal vaginal atrophy.

Parsons A, Merritt D, Rosen A, Heath H 3rd, Siddhanti S, Plouffe L Jr; Study Groups on the Effects of Raloxifene HCI With Low-Dose Premarin Vaginal Cream.

Obstet Gynecol. 2003 Feb;101(2):346-52.

PMID:
12576260
6.

17beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis.

Rioux JE, Devlin C, Gelfand MM, Steinberg WM, Hepburn DS.

Menopause. 2000 May-Jun;7(3):156-61.

PMID:
10810960
7.

Local oestrogen for vaginal atrophy in postmenopausal women.

Suckling J, Lethaby A, Kennedy R.

Cochrane Database Syst Rev. 2003;(4):CD001500. Review. Update in: Cochrane Database Syst Rev. 2006;(4):CD001500.

PMID:
14583935
8.

Effect of raloxifene on sexual function in postmenopausal women.

Kessel B, Nachtigall L, Plouffe L, Siddhanti S, Rosen A, Parsons A.

Climacteric. 2003 Sep;6(3):248-56.

PMID:
14567773
9.

Women's preferences toward attributes of local estrogen therapy for the treatment of vaginal atrophy.

Mattsson LÅ, Ericsson Å, Bøgelund M, Maamari R.

Maturitas. 2013 Mar;74(3):259-63. doi: 10.1016/j.maturitas.2012.12.004. Epub 2013 Jan 9.

PMID:
23312488
10.

Improved compliance and patient satisfaction with estradiol vaginal tablets in postmenopausal women previously treated with another local estrogen therapy.

Minkin MJ, Maamari R, Reiter S.

Int J Womens Health. 2013;5:133-9. doi: 10.2147/IJWH.S41897. Epub 2013 Mar 15.

11.

Systemic effects of conjugated equine estrogen vaginal cream on bone turnover markers in postmenopausal women.

Luengratsameerung S, Panyakhamlerd K, Treratanachat S, Taechakraichana N.

Climacteric. 2013 Feb;16(1):133-40. doi: 10.3109/13697137.2012.662252. Epub 2012 Apr 19.

PMID:
22515801
12.

Plasma estrogen concentrations after oral and vaginal estrogen administration in women with atrophic vaginitis.

Dorr MB, Nelson AL, Mayer PR, Ranganath RP, Norris PM, Helzner EC, Preston RA.

Fertil Steril. 2010 Nov;94(6):2365-8. doi: 10.1016/j.fertnstert.2010.03.076. Epub 2010 May 13.

PMID:
20466363
13.

Twice-weekly synthetic conjugated estrogens vaginal cream for the treatment of vaginal atrophy.

Freedman M, Kaunitz AM, Reape KZ, Hait H, Shu H.

Menopause. 2009 Jul-Aug;16(4):735-41. doi: 10.1097/gme.0b013e318199e734.

PMID:
19252451
14.
15.

Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on vaginal atrophy: a randomized controlled trial.

Fernandes T, Costa-Paiva LH, Pedro AO, Baccaro LF, Pinto-Neto AM.

Menopause. 2016 Jul;23(7):792-8. doi: 10.1097/GME.0000000000000613.

PMID:
27116462
16.
17.

Treatment of urogenital atrophy with low-dose estradiol: preliminary results.

Santen RJ, Pinkerton JV, Conaway M, Ropka M, Wisniewski L, Demers L, Klein KO.

Menopause. 2002 May-Jun;9(3):179-87.

PMID:
11973441
18.

Effect of Foeniculum vulgare (fennel) vaginal cream on vaginal atrophy in postmenopausal women: A double-blind randomized placebo-controlled trial.

Yaralizadeh M, Abedi P, Najar S, Namjoyan F, Saki A.

Maturitas. 2016 Feb;84:75-80. doi: 10.1016/j.maturitas.2015.11.005. Epub 2015 Nov 12.

PMID:
26617271
19.

Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginally.

Bachmann G, Bouchard C, Hoppe D, Ranganath R, Altomare C, Vieweg A, Graepel J, Helzner E.

Menopause. 2009 Jul-Aug;16(4):719-27. doi: 10.1097/gme.0b013e3181a48c4e.

PMID:
19436223
20.

Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy.

Barentsen R, van de Weijer PH, Schram JH.

Eur J Obstet Gynecol Reprod Biol. 1997 Jan;71(1):73-80.

PMID:
9031963

Supplemental Content

Support Center